Table 7 Distribution of the degree to which physicians are being affected by each pricing strategy
No | Description | Strongly agree | Agree | Neutral | Disagree | Strongly disagree |
|---|---|---|---|---|---|---|
1 | Disclosure of actual price of the product | 54.0% | 30.4% | 10.8% | 3.2% | 1.6% |
2 | Price discounts technique for the product | 38.4% | 42.8% | 15.2% | 1.6% | 2.0% |
3 | Price of the drug and effectiveness of therapy | 61.6% | 28.4% | 7.2% | 0.8% | 2.0% |
4 | Price of medication in relation to quality | 57.6% | 29.6% | 8.8% | 1.6% | 2.4% |
5 | Price competition among pharmaceutical company | 46.0% | 32.4% | 16.8% | 3.6% | 1.2% |
6 | Price for full course therapy | 58.4% | 29.2% | 8.0% | 3.2% | 1.2% |